Siegfried Holding AG
SFZN: XSWX (CHE)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|^m | LOCK|tSh@> | LOCK|J@j>?Z |
Siegfried: Dinamiqs Facility Strengthens Manufacturing Capabilities; Healthy Outlook for 2026
Siegfried continues to strengthen its manufacturing capabilities in the rapidly growing cell and gene therapy market. Its completed facility, Dinamiqs, enables end-to-end manufacturing of viral vector gene therapies from molecule design to aseptic drug product filling.
